The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SLN SILENCE THERAPEUTICS PLC ORD 5P



Income Statement  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
Revenue  0.69 0.16 0.12 0.02 0.00
Operating Profit/(Loss)  -5.79 -26.31 -9.07 -12.13 -9.77
Net Interest  0.01 0.00 0.00 0.00 0.00
Profit Before Tax  -5.74 -26.28 -9.00 -11.98 -9.43
Profit After Tax  -5.74 -26.28 -9.00 -11.09 -6.65
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  -5.74 -26.28 -9.00 -11.09 -6.65
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  -5.74 -26.28 -9.00 -11.09 -6.65
 
Continuing EPS
Earnings per Share - Basic  -1.20p -2.67p -20.00p -22.00p -10.40p
Earnings per Share - Diluted  -1.20p -2.67p -20.00p -22.00p -10.40p
Earnings per Share - Adjusted  -1.20p -2.67p -20.00p -22.00p -10.40p
Continuing and Discontinued EPS
Earnings per Share - Basic  -1.20p -2.67p -20.00p -22.00p -10.40p
Earnings per Share - Diluted  -1.20p -2.67p -20.00p -22.00p -10.40p
Earnings per Share - Adjusted  -1.20p -2.67p -20.00p -22.00p -10.40p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Assets
Non-Current Assets
Property, Plant & Equipment  0.23 0.16 0.22 0.46 1.09
Intangible Assets  29.31 7.86 7.80 7.08 6.67
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.00
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.23
  29.54 8.02 8.02 7.54 8.00
Current Assets
Inventories  0.00 0.00 0.00 0.00 0.00
Trade & Other Receivables  0.17 0.15 0.39 0.38 1.64
Cash at Bank & in Hand  3.69 8.91 15.89 16.86 51.91
Current Asset Investments  0.00 0.00 5.00 5.00 0.00
Other Current Assets  0.04 0.00 0.00 0.00 0.00
  3.90 9.06 21.28 22.23 53.55
 
Total Assets  33.44 17.08 29.30 29.77 61.55
 
Liabilities
Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Other Current Liabilities  -1.26 -0.96 -1.72 -2.01 -1.12
  -1.26 -0.96 -1.72 -2.01 -1.12
 
Net Current Assets  2.64 8.10 19.56 20.22 52.43
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Provisions  0.00 0.00 0.00 0.00 0.00
Other Non-Current Liabilities  0.00 0.00 0.00 0.00 0.00
  0.00 0.00 0.00 0.00 0.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -1.26 -0.96 -1.72 -2.01 -1.12
 
Net Assets  32.18 16.12 27.58 27.76 60.43
 
Capital & Reserves
Share Capital  5.77 1.87 2.35 2.61 3.49
Share Premium Account  0.00 0.00 0.00 0.00 0.00
Other Reserves  84.18 97.17 117.09 128.11 166.37
Retained Earnings  -57.77 -82.93 -91.87 -102.96 -109.44
Shareholders Funds  32.18 16.12 27.58 27.76 60.43
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  32.18 16.12 27.58 27.76 60.43

Ratios - based on IFRS 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
PE Ratio - Adjusted  -1.81 -1.64 -11.53 -9.36 -16.05
PEG - Adjusted  n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted  n/a n/a n/a n/a n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  0.15p 0.02p 0.27p 0.03p 0.00p
Pre-Tax Profit per Share  -1.23p -2.67p -20.49p -23.76p -14.73p
Operating Margin  -828.67% -16136.20% -7753.85% -80793.33% n/a
Return on Capital Employed  -199.86% -318.32% -45.52% -57.93% -17.54%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  0.50p 0.44p 42.02p 39.69p 77.01p
Net Gearing  -11.46% -55.28% -57.62% -60.73% -85.90%

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address 1 Lyric Square, London, W6 0NB, United Kingdom
Company website http://www.silence-ther...
Market cap(in millions)* £ 76.08
Listing/Admission to trading 05 Jan 2010
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
10-Dec-16
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 1,500
SEDOL B9GTXM6
ISIN number GB00B9GTXM62



SILENCE THER. share fundamentals (SLN)